David Eansor
Overview
David Eansor received an average of $3M in total compensation, including $495K in salary, at Bio-Techne from 2017 to 2022.
2022Bio-TechneFormer President, Protein Sciences
2021Bio-TechneFormer President, Protein Sciences
2020Bio-TechneFormer President, Protein Sciences
2019Bio-TechneSenior Vice President Biotechnology
2018Bio-TechneSenior Vice President Biotechnology
2017Bio-TechneSenior Vice President Biotechnology
Source: SEC filings on September 14, 2022 and September 9, 2019.
Related executives
We found eight more executives who work or worked at Bio-Techne.
Charles Kummeth
Bio-Techne
Chief Executive Officer
James Hippel
Bio-Techne
Chief Financial Officer
Brenda Furlow
Bio-Techne
General Counsel
Kim Kelderman
Bio-Techne
President, Diagnostics and Genomics
William Geist
Bio-Techne
President, Protein Sciences
Marcel Veronneau
Bio-Techne
Vice President Hematology Operations
Gregory Melsen
Bio-Techne
Chief Financial Officer
Thomas Oland
Bio-Techne